{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:36:20Z","timestamp":1782246980962,"version":"3.54.5"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.2146\/ajhp160737","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T06:35:34Z","timestamp":1506321334000},"page":"1545-1548","source":"Crossref","is-referenced-by-count":13,"title":["Management of amiodarone extravasation with intradermal hyaluronidase"],"prefix":"10.1093","volume":"74","author":[{"given":"Ashley N.","family":"Fox","sequence":"first","affiliation":[{"name":"University of Oklahoma College of Pharmacy, Oklahoma City, OK and OU Medical Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Villanueva","sequence":"additional","affiliation":[{"name":"OU Medical Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041604415584300_b1-0741545","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.amjmed.2015.08.039","article-title":"Practical management guide for clinicians who treat patients with amiodarone","volume":"129","author":"Epstein","year":"2016","journal-title":"Am J Med"},{"key":"2019041604415584300_b2-0741545","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s001340000668","article-title":"Intravenous amiodarone in intensive care: time for a reappraisal?","volume":"26","author":"Hughes","year":"2000","journal-title":"Intensive Care Med"},{"key":"2019041604415584300_b3-0741545","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1592\/phco.22.1.66.33492","article-title":"Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials","volume":"22","author":"Hilleman","year":"2002","journal-title":"Pharmacotherapy"},{"key":"2019041604415584300_b4-0741545","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4037\/ccn2012139","article-title":"Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone","volume":"32","author":"Boyce","year":"2012","journal-title":"Crit Care Nurse"},{"key":"2019041604415584300_b5-0741545","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/hrt.2005.086157","article-title":"Amiodarone induced skin necrosis","volume":"92","author":"Russell","year":"2006","journal-title":"Heart"},{"key":"2019041604415584300_b6-0741545","first-page":"1279","article-title":"The incidence of phlebitis with intravenous amiodarone at guideline dose recommendations","volume":"172","author":"Slim","year":"2007","journal-title":"Mil Med"},{"key":"2019041604415584300_b7-0741545","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/phar.1396","article-title":"Management of extravasation injuries: a focused evaluation of noncytotoxic medications","volume":"34","author":"Reynolds","year":"2014","journal-title":"Pharmacotherapy"},{"key":"2019041604415584300_b8-0741545","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/1060028014527820","article-title":"Extravasation of noncytotoxic drugs: a review of the literature","volume":"48","author":"Le","year":"2014","journal-title":"Ann Pharmacother"},{"key":"2019041604415584300_b9-0741545","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.annemergmed.2008.03.021","article-title":"Medication reconciliation in a rural trauma population","volume":"52","author":"Miller","year":"2008","journal-title":"Ann Emerg Med"},{"key":"2019041604415584300_b10-0741545","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1345\/aph.16487","article-title":"Treatment of extravasation from parenteral nutrition solution","volume":"32","author":"Gil","year":"1998","journal-title":"Ann Pharmacother"},{"key":"2019041604415584300_b11-0741545","doi-asserted-by":"crossref","first-page":"886.e3","DOI":"10.1016\/j.ajem.2012.12.010","article-title":"Identification of highly concentrated dextrose solution (50% dextrose) extravasation and treatment\u2014a clinical report","volume":"31","author":"Lawson","year":"2013","journal-title":"Am J Emerg Med"},{"key":"2019041604415584300_b12-0741545","article-title":"Hyaluronidase [monograph]","volume-title":"Lexicomp Online [online database]"},{"key":"2019041604415584300_b13-0741545","doi-asserted-by":"crossref","first-page":"856541","DOI":"10.1155\/2013\/856541","article-title":"Extravasation injuries in adults","volume":"2013","author":"Al-Benna","year":"2013","journal-title":"ISRN Dermatol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/74\/19\/1545\/28450292\/ajhp1545.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T04:50:28Z","timestamp":1555390228000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/74\/19\/1545\/5103312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,1]]},"references-count":13,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp160737","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,1]]},"published":{"date-parts":[[2017,10,1]]}}}